Cutting not the key to TMPRSS6 activity?
Open Access
- 20 August 2020
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 136 (8) , 922-923
Abstract
In this issue of Blood, Enns et al demonstrate that the mechanism of action of TMPRSS6, a key regulator of iron homeostasis, may differ from early predictions or assumptions.1 This finding has implications not only for our understanding of basic mechanisms of iron biology but also for the development of new pharmacologic agents that exploit or target TMPRSS6 to treat anemias and iron-related diseases.Keywords
This publication has 10 references indexed in Scilit:
- The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in miceBlood, 2020
- Iron metabolism and iron disorders revisited in the hepcidin eraHaematologica, 2020
- Therapeutic Advances in Regulating the Hepcidin/Ferroportin AxisPharmaceuticals, 2019
- Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human HepatocytesCell Chemical Biology, 2019
- SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1HemaSphere, 2019
- RNAi‐mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β‐thalassemia intermediaAmerican Journal of Hematology, 2018
- Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermediaHaematologica, 2015
- Combination therapy with a Tmprss6RNAi‐therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β‐thalassemia intermediaAmerican Journal of Hematology, 2015
- Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in miceJournal of Clinical Investigation, 2013
- An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe−/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermediaBlood, 2013